Research News and Research

RSS

New gene therapy may breach the armor of cancerous tumors

The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Researchers at the Cornell University College of Veterinary Medicine have discovered that inactivation of a DNA repair gene called Hus1 efficiently kills cells lacking p53 -- a gene mutated in the majority of human cancers.

13 Nov 2009

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in Phase I clinical trial development that targets NGF for the treatment of chronic pain.

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

Peplin merges with LEO Pharma

Peplin, Inc. today announced that it has completed its merger with LEO Pharma A/S (LEO) after obtaining the approval of the majority of Peplin stockholders. The deal was originally announced on 3 September, 2009 when LEO, a privately-held, leading global pharmaceutical company within Dermatology and Critical Care, agreed to acquire all outstanding securities of Peplin for approximately US$287.5 million in cash. The merger consideration will be distributed to holders of common stock and CDIs promptly.

13 Nov 2009

New findings on human genome may be useful for developing specific AIDS drugs

The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

13 Nov 2009

Planetree and CMSA seek to improve viable, cost-effective patient-centered care

Planetree, a non-profit organization facilitating efforts to create patient-centered care in healing environments, has entered into a new strategic business alliance with the Case Management Society of America (CMSA), the nation's largest multi-disciplinary professional association for case management.

13 Nov 2009

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

Research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows that an intervention to reduce over-dispensing and waste of asthma medications can succeed without compromising patient safety and can result in substantial cost savings.

13 Nov 2009

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded nearly $9.7 million over five years to the Radiation Effects Research Foundation (RERF), Japan, to study the effects of atomic bomb radiation and aging on the human immune system.

13 Nov 2009

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.

13 Nov 2009

Food science and clinical science join for the first time in a periodical publication

Springer is founding a new journal Food Digestion, dedicated to a quickly growing area of research - food science combined with the physiology of digestion. The journal will publish two issues in 2010 and increase to four issues in 2011.

13 Nov 2009

Mouth: A diagnostic indicator for general health

The mouth or oral cavity area is an excellent indicator of the whole body's health, says Mao, who is the chair of the new Department of Oncology and Diagnostic Sciences at the School.

13 Nov 2009

Report on the epidemiology of PAD, TAO and CLI in India

A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.

13 Nov 2009

Varian and SSI sign reseller's agreement

Varian, Inc. announced today that Steady State Imaging (SSI) has signed a reseller's agreement with Varian, Inc. regarding SSI's new SWIFT Software for Varian's research MRI Systems. SWIFT is a novel MRI technology that advances existing MR techniques with the ability to silently image structures and tissues previously invisible to conventional MRI systems.

13 Nov 2009

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.

13 Nov 2009

African-Americans more likely to die from colorectal cancer than Caucasians, says new study

New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans.

13 Nov 2009

George W. Bush Institute to include global health focus; University of California system launches Global Health Institute

Former President George W. Bush will deliver a speech on Thursday marking the launch of the "George W. Bush Institute as a forum for study and advocacy in four main areas: education, global health, human freedom and economic growth," the New York Times writes.

13 Nov 2009

Senators won't grow deficit without a cost-cutting commission

Congress may outsource its tough budgetary decisions, if moderate, deficit-anxious lawmakers their way. "Several U.S. senators said on Tuesday they probably could force Congress to cede some control to a bipartisan commission that would tackle the United States' looming budget crisis," Reuters reports.

13 Nov 2009

Washington Independent looks at response to newly nominated USAID head

The Washington Independent examines the development community's response to the nomination of Rajiv Shah for USAID administrator. According to the publication,

13 Nov 2009

Timeline, vote counting continue to be central To Senate health overhaul

The Associated Press reports that Senate Majority Leader Harry Reid is considering higher payroll taxes on "upper-income earners to help finance health care legislation.

13 Nov 2009

Research News and Research

New gene therapy may breach the armor of cancerous tumors

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

New and effective medicines underway for treating a wide range of diseases affecting women

Peplin merges with LEO Pharma

New findings on human genome may be useful for developing specific AIDS drugs

Planetree and CMSA seek to improve viable, cost-effective patient-centered care

Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety

LA BioMed to participate in a national study of the effectiveness of testosterone

RERF awarded $9.7M to study the effects of atomic bomb radiation and aging on the human immune system

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Food science and clinical science join for the first time in a periodical publication

Mouth: A diagnostic indicator for general health

Report on the epidemiology of PAD, TAO and CLI in India

Varian and SSI sign reseller's agreement

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

African-Americans more likely to die from colorectal cancer than Caucasians, says new study

George W. Bush Institute to include global health focus; University of California system launches Global Health Institute

Senators won't grow deficit without a cost-cutting commission

Washington Independent looks at response to newly nominated USAID head

Timeline, vote counting continue to be central To Senate health overhaul

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring